On-Demand Downstream Manufacturing Webinars
-
AAV Purification: Solving Downstream Challenges
6/9/2025
In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.
-
Driving The Expansion Of mRNA Into The Therapeutic Sphere
6/5/2025
Discover the next wave of mRNA therapeutics and how emerging technologies are solving key challenges in downstream processing and analysis to enhance both safety and efficacy.
-
Streamlining Vaccine Development, Production With Modality-Specific Purification Tools
6/5/2025
Novel vaccine purification tools are speeding up development for mRNA, viral vectors, and VLPs. Learn how specific chromatography resins can enhance rapid screening and downstream processing.
-
Knowledge Culture: Downstream Innovation
6/2/2025
In this workshop, you’ll learn about various solutions, from cell isolation to cell expansion, that can support autologous and allogeneic cell therapy process needs, digital automation, and mycoplasma testing.
-
Beyond Standard Protein A Resin
6/2/2025
In this study, mAbCapture C affinity resin has been compared with a Protein A resin used in a DSP platform, showing a higher dynamic binding capacity while keeping the product’s critical quality attributes within acceptable limits.
-
Enhancing AAV Purification In Gene Therapy Manufacturing
6/2/2025
Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.
-
Innovation Of Novel Purification Strategies
6/2/2025
In this webinar, we present the development of a novel scavenging resin for clusterin, a persistent CHO host cell protein commonly observed in monoclonal antibody manufacturing processes.
-
Considerations For Affinity Capture In An AAV Platform Downstream Process
6/2/2025
This presentation explores the considerations when evaluating a platform affinity capture step for the purification of AAV vectors. Specificity, binding capacity, purity, yield, scalability and reusability are parameters that will be addressed.
-
Advancing Gene Therapy Development With A Multi-Serotype AAV Resin
5/29/2025
In this webinar, leading CDMO ABL and Thermo Fisher will share data on implementation of the POROS™ CaptureSelect™ AAVX affinity resin into such an AAV purification platform, including its performance in purifying several serotypes.
-
Building A Purification Toolkit For An Expanding Variety Of mAb Therapeutics
5/29/2025
Explore techniques for optimizing purification toolkits for various monoclonal antibody formats. This session covers resin and buffer selection for efficient downstream process development.